Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
Standard BioTools (NASDAQ: LAB) has announced its upcoming first quarter 2025 financial results release and conference call schedule. The company will disclose its Q1 2025 results on Tuesday, May 6, 2025, after the market closes.
A conference call and webcast are scheduled for the same day at 4:30 p.m. ET. Investors can participate through the following dial-in numbers:
- US domestic: (888) 346-3970
- International: (412) 902-4297
The webcast will be accessible through the company's Investor Relations page and will be archived at investors.standardbio.com for future reference.
Standard BioTools (NASDAQ: LAB) ha annunciato la pubblicazione dei risultati finanziari del primo trimestre 2025 e il calendario della conference call. La società renderà noti i risultati del primo trimestre 2025 il martedì 6 maggio 2025, dopo la chiusura del mercato.
La conference call e la trasmissione in webcast sono programmate per lo stesso giorno alle 16:30 ET. Gli investitori potranno partecipare chiamando i seguenti numeri:
- USA: (888) 346-3970
- Internazionale: (412) 902-4297
Il webcast sarà disponibile sulla pagina Investor Relations della società e sarà archiviato su investors.standardbio.com per consultazioni future.
Standard BioTools (NASDAQ: LAB) ha anunciado la fecha de publicación de sus resultados financieros del primer trimestre de 2025 y el calendario de la conferencia telefónica. La compañía dará a conocer sus resultados del primer trimestre de 2025 el martes 6 de mayo de 2025, después del cierre del mercado.
La conferencia telefónica y la transmisión en webcast están programadas para el mismo día a las 4:30 p.m. ET. Los inversores podrán participar a través de los siguientes números de llamada:
- EE.UU.: (888) 346-3970
- Internacional: (412) 902-4297
El webcast estará disponible en la página de Relaciones con Inversores de la compañía y se archivará en investors.standardbio.com para futuras consultas.
Standard BioTools (NASDAQ: LAB)가 2025년 1분기 재무 결과 발표 및 컨퍼런스 콜 일정을 공지했습니다. 회사는 2025년 5월 6일 화요일 장 마감 후 1분기 2025년 실적을 발표할 예정입니다.
컨퍼런스 콜과 웹캐스트는 같은 날 오후 4시 30분 ET에 진행됩니다. 투자자들은 아래 전화번호로 참여할 수 있습니다:
- 미국 국내: (888) 346-3970
- 국제: (412) 902-4297
웹캐스트는 회사의 투자자 관계 페이지를 통해 접속 가능하며, 이후 참고를 위해 investors.standardbio.com에 아카이브됩니다.
Standard BioTools (NASDAQ : LAB) a annoncé la publication prochaine de ses résultats financiers du premier trimestre 2025 ainsi que le calendrier de la conférence téléphonique. La société communiquera ses résultats du T1 2025 le mardi 6 mai 2025, après la clôture du marché.
Une conférence téléphonique et un webcast sont prévus le même jour à 16h30 ET. Les investisseurs peuvent participer en composant les numéros suivants :
- États-Unis : (888) 346-3970
- International : (412) 902-4297
Le webcast sera accessible via la page Relations Investisseurs de la société et sera archivé sur investors.standardbio.com pour consultation ultérieure.
Standard BioTools (NASDAQ: LAB) hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 sowie den Zeitplan für die Telefonkonferenz angekündigt. Das Unternehmen wird die Ergebnisse für Q1 2025 am Dienstag, den 6. Mai 2025, nach Börsenschluss bekanntgeben.
Eine Telefonkonferenz und ein Webcast sind am selben Tag um 16:30 Uhr ET geplant. Investoren können über folgende Telefonnummern teilnehmen:
- Inland USA: (888) 346-3970
- International: (412) 902-4297
Der Webcast ist über die Investor-Relations-Seite des Unternehmens zugänglich und wird zur späteren Einsicht auf investors.standardbio.com archiviert.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report first quarter 2025 financial results on Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results and operational progress.
Individuals can access the conference call by dialing:
US domestic callers: (888) 346-3970
Outside US callers: (412) 902-4297
Live audio of the webcast will be available online on the Investor Relations page of the Company’s website at Events & Presentations. The webcast will be archived and available on Standard BioTools™ Investor Relations page at investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn, and YouTube™.
Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms.
Patent and License Information: standardbio.com/legal/notices.
©2025 Standard BioTools Inc. All rights reserved.
Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.
Investor Contact:
David Holmes
ir@standardbio.com
FAQ
When will Standard BioTools (LAB) release Q1 2025 earnings?
How can investors join Standard BioTools (LAB) Q1 2025 earnings call?
Where can I find the replay of LAB's Q1 2025 earnings webcast?
What time is Standard BioTools (LAB) Q1 2025 earnings call?
